Brokerages expect Alteryx Inc (NYSE:AYX) to report earnings per share (EPS) of ($0.05) for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Alteryx’s earnings. The lowest EPS estimate is ($0.06) and the highest is ($0.04). Alteryx reported earnings per share of $0.02 in the same quarter last year, which indicates a negative year-over-year growth rate of 350%. The business is scheduled to report its next quarterly earnings results on Thursday, November 8th.
On average, analysts expect that Alteryx will report full-year earnings of ($0.25) per share for the current financial year, with EPS estimates ranging from ($0.26) to ($0.24). For the next fiscal year, analysts expect that the company will report earnings of ($0.15) per share, with EPS estimates ranging from ($0.21) to ($0.08). Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Alteryx.
Alteryx (NYSE:AYX) last posted its earnings results on Wednesday, August 8th. The company reported ($0.09) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.10) by $0.01. Alteryx had a negative return on equity of 9.44% and a negative net margin of 9.44%. The company had revenue of $46.80 million during the quarter, compared to the consensus estimate of $43.79 million. During the same quarter last year, the firm earned ($0.09) earnings per share. The company’s revenue was up 54.5% on a year-over-year basis.
A number of equities research analysts have recently weighed in on AYX shares. Needham & Company LLC lifted their target price on Alteryx from $43.00 to $51.00 and gave the stock a “buy” rating in a report on Monday, August 6th. Zacks Investment Research downgraded Alteryx from a “hold” rating to a “sell” rating in a report on Tuesday, August 14th. Citigroup lifted their target price on Alteryx from $57.00 to $61.00 and gave the stock a “buy” rating in a report on Thursday, August 9th. DA Davidson lifted their target price on Alteryx to $52.00 and gave the stock a “neutral” rating in a report on Thursday, August 9th. Finally, JMP Securities lifted their target price on Alteryx from $45.00 to $52.00 and gave the stock a “market outperform” rating in a report on Thursday, August 9th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $49.50.
In related news, Chairman Dean Stoecker sold 40,000 shares of the business’s stock in a transaction dated Wednesday, October 10th. The stock was sold at an average price of $50.79, for a total value of $2,031,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO Robert Scott Jones sold 4,167 shares of the business’s stock in a transaction dated Friday, August 31st. The shares were sold at an average price of $57.33, for a total value of $238,894.11. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,483,986 shares of company stock valued at $192,330,521. 39.01% of the stock is owned by insiders.
A number of hedge funds have recently bought and sold shares of the stock. Northern Trust Corp raised its stake in Alteryx by 19.8% in the second quarter. Northern Trust Corp now owns 326,679 shares of the company’s stock valued at $12,467,000 after purchasing an additional 53,939 shares in the last quarter. Bank of New York Mellon Corp grew its position in Alteryx by 6.4% in the second quarter. Bank of New York Mellon Corp now owns 114,798 shares of the company’s stock valued at $4,380,000 after acquiring an additional 6,898 shares during the last quarter. Carnegie Capital Asset Management LLC grew its position in Alteryx by 4.9% in the second quarter. Carnegie Capital Asset Management LLC now owns 60,510 shares of the company’s stock valued at $3,333,000 after acquiring an additional 2,800 shares during the last quarter. California Public Employees Retirement System grew its position in Alteryx by 57.9% in the second quarter. California Public Employees Retirement System now owns 11,846 shares of the company’s stock valued at $452,000 after acquiring an additional 4,346 shares during the last quarter. Finally, Putnam Investments LLC grew its position in Alteryx by 149.4% in the second quarter. Putnam Investments LLC now owns 35,019 shares of the company’s stock valued at $1,336,000 after acquiring an additional 20,977 shares during the last quarter. 42.94% of the stock is owned by institutional investors and hedge funds.
Shares of AYX traded up $1.59 during midday trading on Monday, reaching $46.93. 1,124,660 shares of the stock were exchanged, compared to its average volume of 835,516. Alteryx has a twelve month low of $20.69 and a twelve month high of $63.18. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.71 and a current ratio of 2.71. The company has a market capitalization of $3.48 billion, a P/E ratio of -151.39 and a beta of 0.27.
Alteryx Company Profile
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts. Its software platform includes Alteryx Designer for data preparation, blending, and analytics that could be deployable in the cloud and on premise; Alteryx Server, a secure and scalable server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models to production; and Alteryx Analytics Gallery, a cloud-based collaboration offering that allows users to share workflows in a centralized repository.
Read More: Why Dividend Stocks May Be Right for You
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.